Stock TMCI TREACE MEDICAL CONCEPTS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Market Closed - Nasdaq
Other stock markets
 21:00:00 28/06/2024 BST 		5-day change 1st Jan Change
6.65 USD +0.15% Intraday chart for Treace Medical Concepts, Inc. +11.95% -47.84%
06-24 Treace Medical Concepts, Inc.(NasdaqGS:TMCI) dropped from S&P Healthcare Equipment Select Industry Index CI
05-29 Treace Medical Concepts Insider Bought Shares Worth $253,475, According to a Recent SEC Filing MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Treace Medical Concepts, Inc.(NasdaqGS:TMCI) dropped from S&P Healthcare Equipment Select Industry Index
CI
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
PR
Treace Medical Concepts Insider Bought Shares Worth $253,475, According to a Recent SEC Filing
MT
Treace to Present at Truist Securities MedTech Conference
AQ
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
PR
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Treace Medical Concepts, Inc. (TMCI)
BU
North American Morning Briefing : The "Everything -2-
DJ
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
PR
UBS Downgrades Treace Medical Concepts to Neutral From Buy, Cuts Price Target to $6.50 From $16
MT
Transcript : Treace Medical Concepts, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 02:20 PM
Top Midday Decliners
MT
UBS Adjusts Price Target on Treace Medical Concepts to $16 From $17, Maintains Buy Rating
MT
Truist Downgrades Treace Medical Concepts to Hold From Buy, Cuts PT to $7 From $17; Notes Slowing Growth Outlook Amid Rising Competitive Pressures
MT
Top Premarket Decliners
MT
Truist Securities Downgrades Treace Medical Concepts to Hold From Buy, Lowers Price Target to $7 From $17
MT
BTIG Downgrades Treace Medical Concepts to Neutral From Buy
MT
JPMorgan Downgrades Treace Medical Concepts to Neutral From Overweight, Cuts Price Target to $8 From $15
MT
Stifel Downgrades Treace Medical Concepts to Hold From Buy, Cuts Price Target to $6 From $15
MT
Treace Medical Concepts Falls 57% Premarket After Revising 2024 Sales Outlook to $201-$211 Million From $220-$225 Million
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TMCI Stock
  4. News Treace Medical Concepts, Inc.